Monopar Therapeutics (MNPR) Stock buybacks 2024–2025
Monopar Therapeutics (MNPR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$35.0MFY2025 · since FY2024: $0 → $35.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.0M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice